Special Issue: "Emerging Therapies and Strategies in Thalassemia: Toward a New Era in Management"
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
This Special Issue on "Emerging Therapies and Strategies in Thalassemia: Toward a New Era in management" aims to update researchers and clinicians regarding the field of thalassemia syndromes [...].
References
1.
Tartaglione I, Carfora R, Brotto D, Barillari M, Costa G, Perrotta S
. Hearing Loss in Beta-Thalassemia: Systematic Review. J Clin Med. 2022; 11(1).
PMC: 8745164.
DOI: 10.3390/jcm11010102.
View
2.
Origa R, Cinus M, Pilia M, Gianesin B, Zappu A, Orecchia V
. Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload. J Clin Med. 2022; 11(7).
PMC: 8999930.
DOI: 10.3390/jcm11072010.
View
3.
Casale M, Baldini M, Del Monte P, Gigante A, Grandone A, Origa R
. Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with Haemoglobinopathies. J Clin Med. 2022; 11(7).
PMC: 8999784.
DOI: 10.3390/jcm11071826.
View
4.
Meloni A, Pistoia L, Gamberini M, Ricchi P, Cecinati V, Sorrentino F
. The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study. J Clin Med. 2021; 10(23).
PMC: 8658115.
DOI: 10.3390/jcm10235561.
View
5.
Longo F, Piga A
. Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?. J Clin Med. 2022; 11(17).
PMC: 9457499.
DOI: 10.3390/jcm11175119.
View